pharmaceuticals and natural products
This report illustrates the crystal structures of three new inhibitors targeting the mycobacterial regulator EthR which has previously been identified as a novel target for tuberculosis drug boosters. In addition, we describe how the results of our structure determination were used to develop a docking protocol using GOLD for future in silico screening.